P2.05. Canakinumab with Standard of Care for Patients with Advanced NSCLC: T-cell Infiltration Analysis in CANOPY-1 - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Daniel Tan
Meta Tag
Speaker Daniel Tan
Topic Metastatic NSCLC: Immunotherapy - Biomarker
T-cell infiltration
non-small cell lung cancer
IL-1β inhibitor
progression-free survival
overall survival
CD8 tumor-infiltrating lymphocytes
antitumor immune responses
immune desert phenotype
myeloid tumor microenvironment
Powered By